Demystification of GM crop costs: Releasing late blight resistant potato varieties as public goods in developing countries

Benjamin Schiek, G. Hareau, Y. Baguma, Akshat Medakker, D. Douches, F. Shotkoski, M. Ghislain
{"title":"Demystification of GM crop costs: Releasing late blight resistant potato varieties as public goods in developing countries","authors":"Benjamin Schiek, G. Hareau, Y. Baguma, Akshat Medakker, D. Douches, F. Shotkoski, M. Ghislain","doi":"10.1504/IJBT.2016.077942","DOIUrl":null,"url":null,"abstract":"A few studies have reported some of the costs associated with bringing to market genetically-modified (GM) crops but no comprehensive studies exist on the real cost of the entire process of developing and releasing one GM variety by a not-for-profit institution in a developing country for sustainable agriculture. Despite the lack of documented studies, it is commonly assumed that such an undertaking is cost prohibitive, based on mere hearsay, and on two private sector cost assessments. The present study assesses the costs and the time expenditures to two not-for-profit programs, one lead by CIP and the other by Cornell University, of developing a late blight resistant (LBr) potato variety for release in one developing country. CIP's costs run to $1.6 million over eight years, while Cornell's costs amount to $1.4 million over nine years. Exogenous disturbances might result in insignificant increases in cost, but can increase time expenditure significantly. A sensitivity analysis revealed that the total cost is markedly influenced by technical parameters determining the production and identification of the pre-commercial LBr transgenic event.","PeriodicalId":91506,"journal":{"name":"International journal of biotechnology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1504/IJBT.2016.077942","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1504/IJBT.2016.077942","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

A few studies have reported some of the costs associated with bringing to market genetically-modified (GM) crops but no comprehensive studies exist on the real cost of the entire process of developing and releasing one GM variety by a not-for-profit institution in a developing country for sustainable agriculture. Despite the lack of documented studies, it is commonly assumed that such an undertaking is cost prohibitive, based on mere hearsay, and on two private sector cost assessments. The present study assesses the costs and the time expenditures to two not-for-profit programs, one lead by CIP and the other by Cornell University, of developing a late blight resistant (LBr) potato variety for release in one developing country. CIP's costs run to $1.6 million over eight years, while Cornell's costs amount to $1.4 million over nine years. Exogenous disturbances might result in insignificant increases in cost, but can increase time expenditure significantly. A sensitivity analysis revealed that the total cost is markedly influenced by technical parameters determining the production and identification of the pre-commercial LBr transgenic event.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
揭开转基因作物成本的神秘面纱:在发展中国家释放抗晚疫病马铃薯品种作为公共产品
一些研究报告了与将转基因作物推向市场有关的一些成本,但没有关于发展中国家的非营利机构为可持续农业开发和发布一种转基因品种的整个过程的实际成本的全面研究。尽管缺乏有文件证明的研究,但仅仅根据道听途说和两项私营部门费用评估,人们普遍认为这样的工作费用过高。本研究评估了两个非营利性项目的成本和时间支出,一个由CIP领导,另一个由康奈尔大学领导,在一个发展中国家开发抗晚疫病(LBr)马铃薯品种。CIP的8年成本为160万美元,而康奈尔大学的9年成本为140万美元。外源性干扰可能导致成本的不显著增加,但可以显著增加时间支出。敏感性分析表明,总成本受到决定LBr转基因事件生产和鉴定的技术参数的显著影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The CHO cell line as a potentially safer host for cetuximab therapeutic antibody production than the Sp2/0 cell line The yield and price effects of growing genetically modified corn: evidence from the US corn belt Perceptions of types, influences, and how select Central European entrepreneurship ecosystems developed in the biopharmaceutical sector Resistance Development in Multi-Drug Resistant Bacteria to Antimicrobials from Methanolic Extract of The Stem Bark of Artocarpus altilis Bioactivity studies of an endangered medicinal plant Celastrus paniculatus willd.: an overview
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1